e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD - treatment II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of iptkalim hydrochloride on endothelin-1-induced pulmonary hypertension in rats
H. Wang, X. Zhang, W. Xie (Nanjing, China)
Source:
Annual Congress 2005 - COPD - treatment II
Session:
COPD - treatment II
Session type:
Thematic Poster Session
Number:
1940
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Wang, X. Zhang, W. Xie (Nanjing, China). Effects of iptkalim hydrochloride on endothelin-1-induced pulmonary hypertension in rats. Eur Respir J 2005; 26: Suppl. 49, 1940
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effect of roflumilast on hypoxia- and monocrotaline-induced pulmonary hypertension in rats
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Effects of Sildenafil on hypoxic pulmonary vasoconstriction in dogs
Source: Eur Respir J 2001; 18: Suppl. 33, 490s
Year: 2001
TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Effects of prostacyclin analogous iloprost trometamol on bleomisin induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of leptin and endothelin-1
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Effects of fasudil in patients with high-altitude pulmonary hypertension
Source: Eur Respir J 2012; 39: 496-498
Year: 2012
Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil
Source: Eur Respir J 2010; 36: 800-807
Year: 2010
Effects of iloprost and the phosphodiesterase inhibitor tolafentrine on pulmonary vascular remodelling in chronic experimental pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 20s
Year: 2003
The effect of acetazolamide on pulmonary hypertension induced by chronic hypoxia in rats
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Effects of the NO donor molsidomine on prostacyclin synthase gene expression in rats with chronic hypoxic pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001
Intrapulmonary shunt effect induces by nicardipine but not by urapidil in pulmonary hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Hypoxia-induced pulmonary hypertension: Synergistic effects of sildenafil and erythropoietin in mice
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
VIP greatly attenuates monocrotaline-induced pulmonary vasculopathy in rats
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009
Effects of HIV protease inhibitors on monocrotaline-induced pulmonary hypertension in rats
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
Acute effects of Sildenafil and Iloprost in pulmonary hypertension of various aetiology
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002
Effect of zamicastat, a dopamine beta-hydroxylase inhibitor, on the monocrotaline rat model of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
2-Methoxyestrone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
The effect of montelukast on the monocrotaline induced pulmonary disease in the wistar rat
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept